612 related articles for article (PubMed ID: 33099131)
21. Parkinson's disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions.
Baldini F; Hertel J; Sandt E; Thinnes CC; Neuberger-Castillo L; Pavelka L; Betsou F; Krüger R; Thiele I;
BMC Biol; 2020 Jun; 18(1):62. PubMed ID: 32517799
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of Gut Microbiota in Patients with GH-Secreting Pituitary Adenoma.
Lin B; Wang M; Gao R; Ye Z; Yu Y; He W; Qiao N; Ma Z; Ji C; Shi C; Zhou X; Wang Y; Zeng F; Zhang L; Gong W; Cao Z; Zhou P; Melnikov V; Ye H; Li Y; Zhang Z; He M; Qin H; Zhang Y
Microbiol Spectr; 2022 Feb; 10(1):e0042521. PubMed ID: 35019688
[TBL] [Abstract][Full Text] [Related]
23. Bacterial Metabolites Mirror Altered Gut Microbiota Composition in Patients with Parkinson's Disease.
van Kessel SP; El Aidy S
J Parkinsons Dis; 2019; 9(s2):S359-S370. PubMed ID: 31609701
[TBL] [Abstract][Full Text] [Related]
24. Urolithins: potential biomarkers of gut dysbiosis and disease stage in Parkinson's patients.
Romo-Vaquero M; Fernández-Villalba E; Gil-Martinez AL; Cuenca-Bermejo L; Espín JC; Herrero MT; Selma MV
Food Funct; 2022 Jun; 13(11):6306-6316. PubMed ID: 35611932
[TBL] [Abstract][Full Text] [Related]
25. Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson's disease.
Rosario D; Bidkhori G; Lee S; Bedarf J; Hildebrand F; Le Chatelier E; Uhlen M; Ehrlich SD; Proctor G; Wüllner U; Mardinoglu A; Shoaie S
Cell Rep; 2021 Mar; 34(9):108807. PubMed ID: 33657381
[TBL] [Abstract][Full Text] [Related]
26. Gut microbiota dysbiosis in a cohort of patients with psoriasis.
Hidalgo-Cantabrana C; Gómez J; Delgado S; Requena-López S; Queiro-Silva R; Margolles A; Coto E; Sánchez B; Coto-Segura P
Br J Dermatol; 2019 Dec; 181(6):1287-1295. PubMed ID: 30920647
[TBL] [Abstract][Full Text] [Related]
27. Gut Microbiota and Parkinson's Disease: Implications for Faecal Microbiota Transplantation Therapy.
Kang Y; Kang X; Zhang H; Liu Q; Yang H; Fan W
ASN Neuro; 2021; 13():17590914211016217. PubMed ID: 34053243
[TBL] [Abstract][Full Text] [Related]
28. Parkinson's Disease and the Gut Microbiome in Rural California.
Zhang K; Paul KC; Jacobs JP; Chou HL; Duarte Folle A; Del Rosario I; Yu Y; Bronstein JM; Keener AM; Ritz B
J Parkinsons Dis; 2022; 12(8):2441-2452. PubMed ID: 36442206
[TBL] [Abstract][Full Text] [Related]
29. Colonic bacterial composition in Parkinson's disease.
Keshavarzian A; Green SJ; Engen PA; Voigt RM; Naqib A; Forsyth CB; Mutlu E; Shannon KM
Mov Disord; 2015 Sep; 30(10):1351-60. PubMed ID: 26179554
[TBL] [Abstract][Full Text] [Related]
30. Alterations of gut microbiota and metabolome with Parkinson's disease.
Yan Z; Yang F; Cao J; Ding W; Yan S; Shi W; Wen S; Yao L
Microb Pathog; 2021 Nov; 160():105187. PubMed ID: 34530073
[TBL] [Abstract][Full Text] [Related]
31. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
[TBL] [Abstract][Full Text] [Related]
32. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Induced Parkinson's Disease in Mouse: Potential Association between Neurotransmitter Disturbance and Gut Microbiota Dysbiosis.
Zhu Y; Huan F; Wang J; Xie X; Yu G; Wang X; Jiang L; Gao R; Xiao H; Ding H; Wang J
ACS Chem Neurosci; 2020 Oct; 11(20):3366-3376. PubMed ID: 32926778
[TBL] [Abstract][Full Text] [Related]
33. Dysbiosis signatures of gut microbiota in coronary artery disease.
Zhu Q; Gao R; Zhang Y; Pan D; Zhu Y; Zhang X; Yang R; Jiang R; Xu Y; Qin H
Physiol Genomics; 2018 Oct; 50(10):893-903. PubMed ID: 30192713
[TBL] [Abstract][Full Text] [Related]
34. Altered gut microbiome composition in nontreated plaque psoriasis patients.
Wen C; Pan Y; Gao M; Wang J; Huang K; Tu P
Microb Pathog; 2023 Feb; 175():105970. PubMed ID: 36621696
[TBL] [Abstract][Full Text] [Related]
35. The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on α-synuclein transport.
Nielsen SD; Pearson NM; Seidler K
Brain Res; 2021 Oct; 1769():147609. PubMed ID: 34371014
[TBL] [Abstract][Full Text] [Related]
36. Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
Zeng Y; Chen S; Fu Y; Wu W; Chen T; Chen J; Yang B; Ou Q
J Viral Hepat; 2020 Feb; 27(2):143-155. PubMed ID: 31600845
[TBL] [Abstract][Full Text] [Related]
37. Dysbiosis of gut microbiota inhibits NMNAT2 to promote neurobehavioral deficits and oxidative stress response in the 6-OHDA-lesioned rat model of Parkinson's disease.
Yu J; Meng J; Qin Z; Yu Y; Liang Y; Wang Y; Min D
J Neuroinflammation; 2023 May; 20(1):117. PubMed ID: 37208728
[TBL] [Abstract][Full Text] [Related]
38. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS
J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424
[TBL] [Abstract][Full Text] [Related]
39. Early Dysbiosis and Dampened Gut Microbe Oscillation Precede Motor Dysfunction and Neuropathology in Animal Models of Parkinson's Disease.
Liang F; Chen CY; Li YP; Ke YC; Ho EP; Jeng CF; Lin CH; Chen SK
J Parkinsons Dis; 2022; 12(8):2423-2440. PubMed ID: 36155528
[TBL] [Abstract][Full Text] [Related]
40. Gut microbial dysbiosis is associated with development and progression of radiation enteritis during pelvic radiotherapy.
Wang Z; Wang Q; Wang X; Zhu L; Chen J; Zhang B; Chen Y; Yuan Z
J Cell Mol Med; 2019 May; 23(5):3747-3756. PubMed ID: 30908851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]